Goodwin Procter LLP advised CRISPR Therapeutics on the deal. CRISPR Therapeutics (NASDAQ: CRSP) announced its collaboration agreement with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to develop, manufacture, and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Astorg in the transaction. Astorg completed its acquisition of Corsearch, from Audax Private Equity. Corsearch’s suite of end-to end brand risk and...
You must be a Standard 1 Year member to access this content.
Torys LLP acted for Vertu Capital. On April 21, 2021, Dejero Labs Inc. announced a C$60 million minority recapitalization of the business led by Vertu Capital,...
You must be a Standard 1 Year member to access this content.
Cassels acted as co-counsel to SOCAN on the leave application. In a decision issued on April 22, 2021, the Supreme Court of Canada granted leave to...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Exeter Capital on the deal. Exeter Capital (“Exeter”), a Boston-based private equity firm with extensive experience investing in consumer-facing companies, has partnered with...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling and Galicia Abogados advised on the transaction Gruma S.A.B. de C.V. secured a $200 million loan from The Bank of Nova Scotia (Scotiabank)...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised Jonas Software in connection with the acquisition. On April 6, 2021, Jonas Software announced its acquisition of Omniterm Data Technology Ltd. This acquisition...
You must be a Standard 1 Year member to access this content.
Fasken acted for the underwriters. On March 31, 2021, Leucrotta Exploration Inc. closed its previously announced bought-deal financing of 41,096,000 units of the Company at a price of C$0.73...
You must be a Standard 1 Year member to access this content.
Lewis Brisbois Bisgaard & Smith secured a major win in an appeal of a bad faith insurance action. The court held that the plaintiff, the daughter...
You must be a Standard 1 Year member to access this content.
Hogan Lovells advised NONAGON on the deal. NONAGON (previously named MyHomeDoc) through the U.S. Food and Drug Administration 510(k) clearance process for its N9 multisensory device...
You must be a Standard 1 Year member to access this content.
Dechert advised Antios Therapeutics on the deal. Antios Therapeutics, Inc. (“Antios”) completed its $96 million Series B financing. Antios is a clinical-stage biopharmaceutical company focused on the...
You must be a Standard 1 Year member to access this content.
Jones Day advised Xact Data Discovery on the deal. Xact Data Discovery, a leading international provider of eDiscovery, data management, and managed review services for major...
You must be a Standard 1 Year member to access this content.
